Kurs
+4,11%
Likviditet
0,15 MSEK
Prenumeration
Kalender
Tid* | ||
2025-02-26 | 08:30 | Bokslutskommuniké 2024 |
2024-11-21 | - | Split HEART 100:1 |
2024-11-14 | - | Kvartalsrapport 2024-Q3 |
2024-11-05 | - | Extra Bolagsstämma 2024 |
2024-08-22 | - | Kvartalsrapport 2024-Q2 |
2024-06-10 | - | X-dag ordinarie utdelning HEART 0.00 SEK |
2024-06-07 | - | Årsstämma |
2024-05-08 | - | Kvartalsrapport 2024-Q1 |
2024-02-15 | - | Bokslutskommuniké 2023 |
2023-11-24 | - | Extra Bolagsstämma 2023 |
2023-11-16 | - | Kvartalsrapport 2023-Q3 |
2023-08-24 | - | Kvartalsrapport 2023-Q2 |
2023-06-16 | - | Årsstämma |
2023-06-15 | - | X-dag ordinarie utdelning HEART 0.00 SEK |
2023-06-14 | - | Årsstämma |
2023-05-11 | - | Kvartalsrapport 2023-Q1 |
2023-02-24 | - | Bokslutskommuniké 2022 |
2022-11-18 | - | Kvartalsrapport 2022-Q3 |
2022-08-19 | - | Kvartalsrapport 2022-Q2 |
2022-06-15 | - | X-dag ordinarie utdelning HEART 0.00 SEK |
2022-06-14 | - | Årsstämma |
2022-05-20 | - | Kvartalsrapport 2022-Q1 |
2022-02-24 | - | Bokslutskommuniké 2021 |
2021-11-18 | - | Kvartalsrapport 2021-Q3 |
2021-08-19 | - | Kvartalsrapport 2021-Q2 |
2021-08-05 | - | Extra Bolagsstämma 2021 |
2021-05-20 | - | Kvartalsrapport 2021-Q1 |
2021-05-03 | - | X-dag ordinarie utdelning HEART 0.00 SEK |
2021-02-25 | - | Bokslutskommuniké 2020 |
2020-11-19 | - | Kvartalsrapport 2020-Q3 |
2020-08-20 | - | Kvartalsrapport 2020-Q2 |
2020-08-04 | - | Extra Bolagsstämma 2020 |
2020-05-20 | - | Kvartalsrapport 2020-Q1 |
2020-05-19 | - | X-dag ordinarie utdelning HEART 0.00 SEK |
2020-05-18 | - | Årsstämma |
2020-02-27 | - | Bokslutskommuniké 2019 |
2019-11-21 | - | Kvartalsrapport 2019-Q3 |
2019-08-22 | - | Kvartalsrapport 2019-Q2 |
2019-05-23 | - | Kvartalsrapport 2019-Q1 |
2019-03-27 | - | X-dag ordinarie utdelning HEART 0.00 SEK |
2019-03-26 | - | Årsstämma |
2019-02-27 | - | Bokslutskommuniké 2018 |
2018-11-22 | - | Kvartalsrapport 2018-Q3 |
2018-08-23 | - | Kvartalsrapport 2018-Q2 |
2018-05-24 | - | Årsstämma |
2018-05-17 | - | Kvartalsrapport 2018-Q1 |
2018-05-11 | - | X-dag ordinarie utdelning HEART 0.00 SEK |
2018-02-22 | - | Bokslutskommuniké 2017 |
2017-11-27 | - | Extra Bolagsstämma 2017 |
2017-11-23 | - | Kvartalsrapport 2017-Q3 |
2017-08-24 | - | Kvartalsrapport 2017-Q2 |
2017-05-31 | - | Kvartalsrapport 2017-Q1 |
2017-05-11 | - | X-dag ordinarie utdelning HEART 0.00 SEK |
2017-05-10 | - | Årsstämma |
2017-02-23 | - | Bokslutskommuniké 2016 |
2016-11-24 | - | Kvartalsrapport 2016-Q3 |
2016-08-25 | - | Kvartalsrapport 2016-Q2 |
2016-05-11 | - | Kvartalsrapport 2016-Q1 |
2016-05-10 | - | Årsstämma |
2016-04-20 | - | X-dag ordinarie utdelning HEART 0.00 SEK |
2016-02-18 | - | Bokslutskommuniké 2015 |
2015-11-12 | - | Kvartalsrapport 2015-Q3 |
2015-08-28 | - | Kvartalsrapport 2015-Q2 |
2015-05-26 | - | Kvartalsrapport 2015-Q1 |
2015-05-21 | - | X-dag ordinarie utdelning HEART 0.00 SEK |
2015-05-20 | - | Årsstämma |
2015-02-18 | - | Bokslutskommuniké 2014 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
Västerås, August 9, 2024 – Scandinavian Real Heart AB (publ) announces today that Jimmy Nybom will succeed Andreas Hultdin as interim Chief Financial Officer (CFO) during the ongoing recruitment process of a permanent CFO. Jimmy Nybom will start his assignment on September 6.
Jimmy Nybom holds a Master of Science (MSc) in Business Administration and Economics, with a specialization in Accounting and Finance, from Umeå University. Mr Nybom has previous experience as interim CFO and board member in the public company sphere. He has 18 years of experience as an auditor and advisor at the auditing global firm Grant Thornton, where he has had extensive interaction with Realheart as the company’s auditor during year 2019-2022 and is therefore well-informed about the company’s financials and operations.
Jimmy Nybom will join the company on September 6, succeeding the company’s current interim CFO Andreas Hultdin.
“While the process of recruiting a permanent CFO is progressing according to plan, our interim CFO Andreas Hultdin will be handing over the baton to Jimmy Nybom. Jimmy, who was part of the advisory team that supported the IPO of Realheart, is an acknowledged professional in auditing and financials. We wish to thank Andreas for his valuable contributions and wish him good luck in his future endeavors,” says Ina Laura Perkins, CEO of Realheart.
About Realheart
Scandinavian Real Heart AB (publ) is developing the first artificial heart that mimics the shape, function, and blood flow pattern of the human heart. These unique product features provide completely new opportunities to save lives and give patients a good quality of life while waiting for a heart transplant. Realheart® TAH (Total Artificial Heart) is now being evaluated in extensive preclinical trial models ahead of a first clinical study in patients. In the future, artificial hearts may also become an alternative to transplantation for broader groups of patients with severe heart failure. The company's shares are traded on Nasdaq Stockholm First North Growth Market. For more information, visit www.realheart.se
For more information, please contact:
Ina Laura Perkins, CEO
Phone: +46 (0) 70 406 49 21
E-mail: inalaura.perkins@realheart.se
Certified Adviser: Svensk Kapitalmarknadsgranskning AB, www.skmg.se
Image Attachments
Jimmy Nybom 2024